SC
AGN

Saturna Capital’s Allergan plc AGN Stock Holding History

Saturna Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,283
Closed -$1.12M – 174
2016
Q1 		$1.12M Buy
4,283
+450
+12% +$129K 0.04% 114
2015
Q4 		$1.2M Buy
3,833
+381
+11% +$113K 0.04% 119
2015
Q3 		$938K Buy
3,452
+1,047
+44% +$322K 0.03% 134
2015
Q2 		$772K Buy
2,405
+2,286
+1,921% +$682K 0.02% 144
2015
Q1 		$35K Hold
119
– – ﹤0.01% 296
2014
Q4 		$31K Hold
119
– – ﹤0.01% 305
2014
Q3 		$29K Hold
119
– – ﹤0.01% 345
2014
Q2 		$27K Hold
119
– – ﹤0.01% 353
2014
Q1 		$24K Hold
119
– – ﹤0.01% 319
2013
Q4 		$20K Hold
119
– – ﹤0.01% 318
2013
Q3 		$17K Hold
119
– – ﹤0.01% 335
2013
Q2 		$15K Buy
+119
New +$13.5K ﹤0.01% 344

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Saturna Capital's AGN Position: Q2 2016 in Review

Saturna Capital sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 4,283 shares — an estimated $1.12M sold.

Saturna Capital first reported a position in AGN in Q2 2013 and held it in 12 quarters. The position peaked at $1.2M in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Saturna Capital reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Saturna Capital sold 4,283 Allergan plc shares in Q2 2016, an estimated $1.12M.
  • Saturna Capital first reported a position in Allergan plc in Q2 2013 and held it in 12 quarters.
  • Saturna Capital's Allergan plc position peaked at $1.2M in Q4 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Saturna Capital's 13F filing for Q2 2016, filed 8 Aug 2016.